Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Oncogenesis|June 30, 2018
Identification of strong intron enhancer in the heparanase gene: effect of functional rs4693608 variant on HPSE enhancer activity in hematological and solid malignanciesOlga Ostrovsky, Ania Hava Grushchenko-Polaq, Katia Beider, et al.
Journal of Digestive Diseases|October 30, 2008
Comparative analysis of Bayer wide-range C-reactive protein (wr-CRP) and the Dade-Behring high sensitivity C-reactive protein (hs-CRP) in patients with inflammatory bowel diseaseNitsan Maharshak, Yaron Arbel, Amir Gal-Oz, et al.
Inflammatory Bowel Diseases|April 20, 2013
MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel diseaseNitsan Maharshak, Shani Shenhar-Tsarfaty, Nimrod Aroyo, et al.
European Journal of Haematology|November 7, 2020
A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemiaJonathan Canaani, Ivetta Danylesko, Noga Shemtov, et al.
Oncotarget|December 7, 2017
Dissecting the mechanisms involved in anti-human T-lymphocyte immunoglobulin (ATG)-induced tolerance in the setting of allogeneic stem cell transplantation - potential implications for graft versus host diseaseKatia Beider, David Naor, Valeria Voevoda, et al.
Bone Marrow Transplantation|August 9, 2018
Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysisVipul Sheth, Myriam Labopin, Jonathan Canaani, et al.
Oncotarget|June 25, 2020
Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemiaJonathan Canaani, Meital Nagar, Gabriel Heering, et al.
Annals of Hematology|January 28, 2022
Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocolDanielle Fredman, Yakir Moshe, Ofir Wolach, et al.
American Journal of Hematology|January 5, 2017
Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMTJonathan Canaani, Eric Beohou, Myriam Labopin, et al.
Annals of Hematology|June 23, 2022
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysisShai Shimony, Jonathan Canaani, Eitan Kugler, et al.
Pageof 6